Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care - TIGER Study

NCT03258021 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT03258021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03258021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of TTFields for Newly Diagnosed GBM Patients in Germany in Routine Clinical Care - TIGER Study
Lead sponsor
NovoCure Ltd.
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2017
Completion date
July 31, 2021
Enrollment
710 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma